Literature DB >> 12145228

Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study.

Hendrik A van Leiden1, Jacqueline M Dekker, Annette C Moll, Giel Nijpels, Robert J Heine, Lex M Bouter, Coen D A Stehouwer, Bettine C P Polak.   

Abstract

OBJECTIVE: To study potential risk factors for retinopathy in diabetic and nondiabetic individuals. RESEARCH DESIGN AND METHODS: The Hoorn Study is a population-based study including 2,484 50- to 74-year-old Caucasians. A subsample of 626 individuals stratified by age, sex, and glucose tolerance underwent extensive measurements during 1989-1992, including ophthalmologic examination and two-field 45-degree fundus photography. The prevalence of (diabetic) retinopathy was assessed among individuals with normal glucose metabolism (NGM) and impaired glucose metabolism (IGM) and individuals with newly diagnosed diabetes mellitus (NDM) and known diabetes mellitus (KDM) (new World Health Organization 1999 criteria).
RESULTS: The prevalence of retinopathy was 9% in NGM, 11% in IGM, 13% in NDM, and 34% in KDM. Retinopathy worse than minimal nonproliferative diabetic retinopathy was present in 8% in KDM and 0-2% in other glucose categories. The prevalence of retinopathy was positively associated with elevated blood pressure, BMI, cholesterol, and triglyceride serum levels in all glucose categories. The age-, sex-, and glucose metabolism category-adjusted odds ratios were 1.5 (95% CI 1.2-1.9), 1.3 (1.0-1.7), and 1.3 (1.0-1.6) per SD increase of systolic blood pressure, BMI, and total cholesterol concentration, respectively, and 1.2 (1.0-1.5) per 50% increase of triglyceride level. Elevated blood pressure and plasma total and LDL cholesterol levels showed associations with retinal hard exudates.
CONCLUSIONS: Retinopathy is a multifactorial microvascular complication, which, apart from hyperglycemia, is associated with blood pressure, lipid concentrations, and BMI.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145228     DOI: 10.2337/diacare.25.8.1320

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  100 in total

1.  Statins for prevention of diabetic-related blindness: a new treatment option?

Authors:  Mona F El-Azab; Barbara A Mysona; Azza B El-Remessy
Journal:  Expert Rev Ophthalmol       Date:  2011-06

2.  Oxidised, glycated LDL selectively influences tissue inhibitor of metalloproteinase-3 gene expression and protein production in human retinal capillary pericytes.

Authors:  J L Barth; Y Yu; W Song; K Lu; A Dashti; Y Huang; W S Argraves; T J Lyons
Journal:  Diabetologia       Date:  2007-08-04       Impact factor: 10.122

3.  Association of serum lipid levels with retinal hard exudate area in African Americans with type 2 diabetes.

Authors:  Evangelia Papavasileiou; Samaneh Davoudi; Ramak Roohipoor; Heeyoon Cho; Shreyas Kudrimoti; Heather Hancock; James G Wilson; Christopher Andreoli; Deeba Husain; Maurice James; Alan Penman; Ching J Chen; Lucia Sobrin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-09-15       Impact factor: 3.117

Review 4.  Blood pressure control for diabetic retinopathy.

Authors:  Diana V Do; Xue Wang; Satyanarayana S Vedula; Michael Marrone; Gina Sleilati; Barbara S Hawkins; Robert N Frank
Journal:  Cochrane Database Syst Rev       Date:  2015-01-31

5.  Relationship between body fat and diabetic retinopathy in patients with type 2 diabetes: a nationwide survey in Korea.

Authors:  In Cheol Hwang; Jeong Hun Bae; Joon Mo Kim
Journal:  Eye (Lond)       Date:  2019-02-13       Impact factor: 3.775

6.  Effects of body mass index on intraocular pressure and ocular pulse amplitude.

Authors:  Remzi Karadag; Zeynel Arslanyilmaz; Bahri Aydin; Ibrahim F Hepsen
Journal:  Int J Ophthalmol       Date:  2012-10-18       Impact factor: 1.779

Review 7.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.

Authors:  Elia J Duh; Jennifer K Sun; Alan W Stitt
Journal:  JCI Insight       Date:  2017-07-20

8.  Current and future approaches in the prevention and treatment of diabetic retinopathy.

Authors:  Louis K Chang; David Sarraf
Journal:  Clin Ophthalmol       Date:  2008-06

9.  Retinopathy among type 2 diabetic patients seen at a tertiary hospital in Nigeria: a preliminary report.

Authors:  Adeyinka Ashaye; Ayodeji Arije; Modupe Kuti; Bolutife Olusanya; Ezekiel Ayeni; Adesoji Fasanmade; Kehinde Akinlade; Millicent Obajimi; Jokotade Adeleye
Journal:  Clin Ophthalmol       Date:  2008-03

10.  Prevalence of diabetic retinopathy in Tehran province: a population-based study.

Authors:  Mohammad Ali Javadi; Marzieh Katibeh; Nasrin Rafati; Mohammad Hossein Dehghan; Farid Zayeri; Mehdi Yaseri; Mojtaba Sehat; Hamid Ahmadieh
Journal:  BMC Ophthalmol       Date:  2009-10-16       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.